ADME Services | ADME/Tox Testing Services | Corning

We use cookies to ensure the best experience on our website.
View Cookie Policy
/worldwide/en/corning-cookie-policy.html
_self
Accept Cookie Policy
Change My Settings
ESSENTIAL COOKIES
Required for the site to function.
PREFERENCE AND ANALYTICS COOKIES
Augment your site experience.
SOCIAL AND MARKETING COOKIES
Lets Corning work with partners to enable social features and marketing messages.
ALWAYS ON
ON
OFF

The ADME services you need to make important drug-development decisions.

Take your ADME/Tox testing to completion

Founded in 1992, we stand ready to become an extension of your ADME teamor your virtual ADME partnerto help strengthen your ability to meet your drug discovery and pre-clinical goals.

  • Full range of ADME/Tox services: From permeability, drug absorption, and transport to drug metabolism our services fully support your comprehensive ADME/Tox testing needs.
  • Long track record of success: For more than 20 years, the Corning Gentest Contract Research team has been successfully developing and conducting in vitro drug-drug interaction studies, contributing to hundreds of pharmaceutical discovery and development programs for many of the world's leading pharmaceutical and biotech companies.
  • Skilled Study Directors: Our scientists are experts in the areas of drug absorption, transporters, metabolism, induction, toxicity, and industry/regulatory guidance. We'll work with you to facilitate informed decisions.
  • Alignment with regulatory guidance: Study designs are continually updated to be aligned with current Regulatory Agency guidance. So you can be assured you’ll have the right data for submission to the FDA, EMA, and MHLW-PWDA.
  • Superior Quality: All services are conducted in Corning's GLP-compliant and ISO 9001-certified laboratories. You can depend on our team for accurate, reproducible data and regulatory submission-ready reports.
  • Customization: Whether modifying our standard protocols or adapting the protocols of our clients, Corning has the expertise needed to offer customized solutions to meet your specific needs.

ADME Services

Transporter Interactions

From screening assays to comprehensive drug-drug interaction assessment, we can provide solutions to your ABC efflux and SLC uptake transporter assay needs. We offer diverse study models and assays which comply with FDA/EMA recommended approaches to determine cell permeability and evaluate your compounds as substrates and/or inhibitors of P-gp, BCRP, BSEP, MRPs, OATP1B1, OATP1B3, OAT1, OAT3, OCT1, OCT2, MATE1, MATE2-K, and more.  

Contact Us

Enzyme Inhibition

Our CYP and UGT inhibition services are conducted with Corning UltraPool® HLM 150 pooled human liver microsomes, drug probe substrates and validated LC/MS/MS methods. Options include direct and time-dependent inhibition studies with flexible endpoints. Kinetic results reported include IC50, IC50 shift (dilution and non-dilution methodology), as well as KI and kinact. Assays are also available using hepatocytes or recombinant enzyme study models.

Contact Us

Enzyme Induction

For 20+ years, we have provided regulatory agency-driven cytochrome P450 (CYP) induction services using primary hepatocytes. Testing options include enzyme activity and mRNA endpoints for CYP1A2, CYP2B6, CYP3A4, CYP2C8, CYP2C9, CYP2C19, UGTs, and more. Data may include EC50, Emax or relative induction scores (RIS). Rapid and conventional assay protocols are available which can be modified to your needs.

Contact Us

Reaction Phenotyping

Using our well-known Corning Supersomes™ enzymes, human liver microsomes, or hepatocytes, we will evaluate enzyme-mediated pathways of elimination for your compound. Enzyme-selective chemical inhibitors and/or immune inhibitory antibodies can be used to confirm pathways and evaluate whether your compound could be a “victim” of drug-drug interactions. Available enzymes for evaluation: CYP, UGT, CES, SULT, and AO.

Contact Us

Screening – Discovery Compounds

Corning provides additional services for discovery compounds including:

Rapid in vitro metabolic stability - hepatocytes, S9, liver microsomes - from human and preclinical species
Intrinsic clearance
Permeability - Caco-2, MDCK, LLC-PK1
CYP induction and inhibition screening
Microsomal binding *NEW
Blood to plasma ratio *NEW
Plasma protein binding - rapid equilibrium dialysis (RED)

Contact Us

Custom Assays